Evaluation of Rheumatoid Arthritis Disease Education Literature
NCT ID: NCT03336684
Last Updated: 2020-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
376 participants
INTERVENTIONAL
2017-12-18
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patient education plays an important role in the management of disease. Adequate patient knowledge and awareness about disease may help in incorporating the ailment in daily life. The purpose of this study is to evaluate the benefit of a disease education literature in Urdu language and with culturally relevant illustration for rheumatoid arthritis patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-learning in Patient Education to Patients With Rheumatoid Arthritis
NCT04669340
Patient Education and Rheumatoid Arthritis
NCT07170371
App-based Education and GOal-setting in Rheumatoid Arthritis
NCT05888181
The Effect of an Anti-inflammatory Diet in Patients With Rheumatoid Arthritis
NCT05336513
Impact of Pharmacist Intervention on Disease Knowledge, Rehabilitation and Medication Adherence, Treatment Induced Direct Cost, Health-related Quality of Life and Satisfaction in Patients With Rheumatoid Arthritis
NCT03827148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Education Group
Patients will be provided with disease education literature
Patient education
Rheumatoid arthritis patients will be provided with disease education literature
Normal Group
Patients will not be provided with disease education literature
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient education
Rheumatoid arthritis patients will be provided with disease education literature
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participants who are willing to participate in the study.
Exclusion Criteria
2. Patients currently undergoing surgery or had previous history of surgery.
3. Patients who are not willing to participate.
4. In-patients.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Sains Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Atta Abbas Naqvi
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehfooz Alam, MBBS
Role: PRINCIPAL_INVESTIGATOR
Liaqat National Hospital Karachi
Baqir S Naqvi, PhD
Role: STUDY_DIRECTOR
Hamdard University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clifton Central Hospital
Karachi, Sindh, Pakistan
Liaqat National Hospital
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PACT2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.